Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors

18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For this purpose we conducted a retrospective analysis of all patients with metastatic breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Weide, Rudolf, Feiten, Stefan, Friesenhahn, Vera, Heymanns, Jochen, Kleboth, Kristina, Thomalla, Jörg, van Roye, Christoph, Köppler, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177050/
https://www.ncbi.nlm.nih.gov/pubmed/25279326
http://dx.doi.org/10.1186/2193-1801-3-535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177050/
https://www.ncbi.nlm.nih.gov/pubmed/25279326
http://dx.doi.org/10.1186/2193-1801-3-535

Ejemplares similares